key: cord-0707552-l6weu3uk
authors: Ng, Kok Pin; Chiew, Hui Jin; Hameed, Shahul; Ting, Simon Kang Seng; Ng, Adeline; Soo, See Ann; Wong, Benjamin Y. X.; Lim, Levinia; Yong, Alisa C. W.; Mok, Vincent C. T.; Rosa‐Neto, Pedro; Dominguez, Jacqueline; Kim, SangYun; Hsiung, G. Y. Robin; Ikeda, Manabu; Miller, Bruce L.; Gauthier, Serge; Kandiah, Nagaendran
title: Frontotemporal dementia and COVID‐19: Hypothesis generation and roadmap for future research
date: 2021-01-15
journal: Alzheimers Dement (N Y)
DOI: 10.1002/trc2.12085
sha: 7d93819f45fe3ebf30fd19590235ab1c524e7740
doc_id: 707552
cord_uid: l6weu3uk

The COVID‐19 pandemic has caused tremendous suffering for patients with dementia and their caregivers. We conducted a survey to study the impact of the pandemic on patients with mild frontotemporal dementia (FTD). Our preliminary findings demonstrate that patients with FTD have significant worsening in behavior and social cognition, as well as suffer greater negative consequences from disruption to health‐care services compared to patients with AD. The reduced ability to cope with sudden changes to social environments places patients with FTD at increased vulnerability to COVID‐19 infection as well as to poorer clinical and social outcomes. Caregivers of FTD patients also demonstrate high burden during crisis situations. A proportion of patients with FTD benefitted from use of web‐based interactive platforms. In this article, we outline the priority areas for research as well as a roadmap for future collaborative research to ensure greatest benefit for patients with FTD and their caregivers.

SARS-CoV-2 is a novel coronavirus that has rapidly spread to different parts of the world since its first report in December 2019. 1, 2 This has led to the World Health Organization (WHO) declaring the coronavirus disease 2019 (COVID-19) a pandemic in March 2020. As of July 18, 2020, >13 million confirmed cases and 591 000 confirmed deaths have been reported by the WHO. 3 In these unprecedented times, authori- 

Frontotemporal dementia (FTD) is one of the most common causes of early-onset dementia in people under the age of 65 years. 8, 9 FTD is a phenotypically diverse disease and is classified into behavioral variant FTD (bvFTD) and language variant FTD (lvFTD) such as those with nonfluent variant primary progressive aphasia and semantic variant primary progressive aphasia. 10, 11 Patients with bvFTD display behavioral changes including disinhibition, loss of empathy, and apathy. In addition, they may also display perseverative and compulsive behaviors. 10 Patients with FTD display cognitive impairment including executive dysfunction, impaired social cognition, and progressive language difficulty such as agrammatism and loss of semantic knowledge. 12,13

The clinical manifestations of FTD will likely make patients less able to comply with the social and personal distancing requirements imposed by the authorities, and infection control advice such as regular hand washing and wearing facemasks in the community. Perseverative, stereotyped, or compulsive behaviors may result in habits such as frequent touching of the nose or mouth or wandering out of the home environment, thus increasing risk of transmitting the infection. 14 Many of the behavioral and cognitive changes seen in FTD also increase the susceptibility of FTD patients to acquiring the COVID-19 infec- 

FTD is characterized by changes in behavior, including disinhibition, loss of empathy, apathy, and perseverative or compulsive behaviors. 10 Patients may also have repetitive behaviors. Some may also have psychotic symptoms including hallucinations and delusions. 15 pandemic. Anosognosia and accompanying lack of emotional concern may manifest as disregard of requirements for social distancing or use of facemasks.

In addition to behavioral changes, worsening of cognitive function such as deterioration in executive function and language further results in difficulty coping with social restrictions. 17 The frontal-executive dys- Risk factors for high caregiver burden in young onset dementia include family history of dementia and behavioral symptoms including disinhibited behavior, delusions, and apathy. 23 Cost of caring for patients with young onset dementia such as FTD is significantly higher than late onset dementia, which further compounds the burden of care in FTD. 24, 25 These potential effects of COVID-19 pandemic on FTD patients may place additional stress on caregivers who are already overburdened. 26 

To understand the extent to which patients with mild FTD and their caregivers were affected by the pandemic, we conducted a phonebased survey using a structured questionnaire with 50 patients with mild FTD and 50 patients with mild AD dementia, matched for age and severity of cognitive impairment (see the Appendix). The aim of the survey was to identify major themes of particular concern to patientcaregiver dyads of FTD. The survey probed themes of behavior, cognition, disruption to health-related services, coping mechanisms, and use of technology as an alternative platform to traditional caregiving.

Findings from this preliminary survey were meant to allow for hypothesis generation for future studies in the field of FTD and COVID-19.

We additionally obtained opinions from international experts in FTD on strategies for further research into how FTD patients can be better prepared to meet challenges of future calamities.

Findings from the survey demonstrated that behavior symptoms significantly worsened in both FTD and AD with greater worsening in FTD (84% vs 58%, P = .008). The main behavioral issues in FTD included stereotypic behavior, apathy, and disinhibition ( Figure 1 ). Patients also reported difficulty adapting to the social changes brought on by the pandemic such as planning their grocery shopping. Symptoms related to planning and judgment were observed in both FTD and AD patients and the difference was not statistically significant (84% vs 76%, P = ns).

Patients with FTD had greater difficulty empathizing with the public when it came to measures such as when disabled individuals were allowed to join priority queues, suggesting that aspects of social cognition were significantly affected in FTD compared to AD (62% vs 16%, P < .001). Impaired social cognition has severe implications on ability of FTD patients to "care about" or "comply with" social personal restrictions. Thirty percent of FTD patients and 40% of AD patients in the survey were using web-based platforms to stay connected to family, friends, and support groups ( Figure 2 ). Web-based platforms could be a strategy to help FTD and AD patients cope with future calamities.

Patients with FTD reacted more adversely to disruption of care ser- 

The current survey is of relatively small sample size, limited to persons with mild dementia and as the FTD patients were recruited from a single center, lacks generalizability. The findings also suffer from lim-itations associated with phone surveys such as lack of objective measures and recall bias. However, the survey findings were meant to provide preliminary data for hypothesis generation for future prospective studies. Data on how FTD patients in other cultural and social settings respond to the pandemic is urgently needed. While the current findings demonstrate that behavior was severely affected, further research is required to understand which behavior subtypes worsened most, and if the worsening of behavior was due to worsening of specific pre-existing behaviors or related to onset of new behaviors. Due to the relatively small sample size, we were not able to study if patients with bvFTD and lvFTD respond differentially to the pandemic and this should be addressed in a larger multicenter study. There is also need for data on FTD patients who were infected with COVID-19 to clearly understand the consequences of COVID-19 infection on clinical profile of FTD, general health, and mortality.

The finding of significantly greater worsening of behavior and social cognition in FTD compared to AD is likely related to the underlying pathobiology of FTD. Disinhibition, attributed to pathology in the right middle temporal and inferior frontal regions, may manifest as loss of manners, use of abusive language, and impulsivity. 27 Pathology in the prefrontal cortex among FTD patients has also been shown to result in significant lack of insight into their disease and additionally a lack of emotional concern about their behaviors. [28] [29] [30] In FTD, increased activity of dopaminergic neurotransmission and altered serotonergic modulation of dopaminergic neurotransmission is associated with agitated and aggressive behavior, respectively. 31 

While the preliminary findings have provided a better understanding of the impact of COVID-19 on FTD, further research is urgently needed to identify which subtype of FTD patients react more poorly to crisis situations. Studies would need to focus on FTD subtypes based on clinical phenotype as well as pathological subtypes. Research into neural mechanisms that result in a differential response between FTD and AD in a pandemic may allow for tailored interventional strategies for both FTD and AD. From a management perspective, studies examining the potential to reduce the adverse response of FTD patients to a crisis with the use of a multidisciplinary online platform that includes telehealth, virtual support groups, virtual mental health programs and virtual physical stimulation will be of high relevance. Similarly, studies looking into preparing caregivers of FTD patients to be "crisis ready"

and resources for such a strategy will be needed.

There is a need for closer collaboration among clinicians worldwide as well as among clinicians, scientists, and public health authorities to bet- rhythm, temperature, oxygen saturation), may also enable collection and analyses of big data and development of technologies to improve safety and rehabilitation for patients with FTD. 35 Concerted efforts by regional and international groups to analyze pooled FTD data would allow for development of a global resource pool for FTD patients worldwide.

Roadmap toward multidisciplinary research on the impact of the COVID-19 pandemic on frontotemporal dementia. A roadmap describing future research strategies toward closer collaboration among clinicians worldwide as well as among clinicians, scientists, and public health authorities to better help patients with FTD and their caregivers cope with a crisis such as the COVID-19 pandemic. CSF, cerebrospinal fluid; fMRI, functional magnetic resonance imaging; FTD, frontotemporal dementia; FTLD, frontotemporal lobar degeneration; MRI, magnetic resonance imaging

Patients with FTD respond adversely to rapid changes to social environments with significant worsening in behavior and social cognition compared to patients with AD. Patients with FTD also suffer more when there is disruption to care services. Caregivers of patients with FTD experience greater caregiver burden compared to caregivers of patients with AD. Based on the preliminary findings, we outline the areas for future research and a roadmap to strategize research into FTD in the setting of a crisis. Such a concerted effort is likely to benefit FTD patients worldwide and their caregivers not only during the ongoing prolonged COVID-19 pandemic but also for other similar crisis situations which the world is witnessing more frequently.

We pay tribute to all health-care staff, front-line staff, and caregivers for their non-wavering commitment to patients with dementia worldwide during the ongoing COVID-19 pandemic. We also thank Dr Zaven

Khachaturian and Dr Ara Khachaturian for guiding us on the scope of this article and Professor Martin Rossor for his contributions toward this manuscript.

The authors report no conflicts of interest. 

Specialists in the field of FTD who have ongoing collaborations with the National Neuroscience Institute, Singapore were invited to share their perspectives on what measures could be taken to reduce the impact of the COVID-19 pandemic on FTD patients. Specialists were also asked to share potential strategies for concerted research toward finding solutions to assist patients with FTD cope with future crisis.

Statistical analyses were performed using Statistical Package for Social Sciences (SPSS) version 26 (SPSS, Inc.; Chicago, Illinois, USA).

Descriptive statistics and frequency of baseline characteristics were summarized and compared between FTD and AD groups using two independent samples t-test and chi-square test for continuous and categorical variables respectively. Multiple binary logistic regression was performed to investigate the association of questionnaire responses with FTD and AD groups, controlling for age and years of education.

Statistical significance was set at P < .05.

The study was approved by the Singhealth Centralized Review Board.

Informed consent was obtained from each patient according to Declaration of Helsinki and local clinical research regulations.

One hundred patients (50 mild FTD and 50 mild AD) were included in this study and the baseline demographics of the study cohort and their caregivers are summarized in Table 1. The FTD patients included 37 with bvFTD and 13 with lvFTD. There were no statistical differences in the demographics, Mini-Mental State Examination (MMSE) scores and disease duration between FTD and AD (Table 1 ).

In the section of the questionnaire that evaluated patient's cognitive and behavioral response to the COVID-19 pandemic, a greater proportion of FTD patients compared to AD patients reported worsening of behavioral symptoms (84% vs 58%, P = .008) and worsening social cognition (62% vs 16%, P < .001), Figure 1 . Both FTD and AD patients reported worsening of executive function, though the difference was not statistically significant (84% vs 76%, P = ns). More patients with AD reported worsening of memory compared to FTD, though the difference was not statistically significant (34% vs 24%, P = ns).

In the section of the questionnaire that evaluated the impact of the COVID-19 pandemic on FTD and AD patients, a greater proportion of FTD patients compared to AD patients reported that their symptoms worsened due to disruption of their usual health care, such as medical appointments and therapy sessions (42% vs 20%, P = .012), Figure 2 . A greater proportion of caregivers of FTD patients compared to caregivers of AD patients reported increased burden as a result of the COVID-19 pandemic (64% vs 42%, P = .023). Thirty percent of FTD patients and 40% of AD patients reported that they were able to use web-based platforms to maintain their usual communications with family, friends, and support services.

A novel coronavirus from patients with pneumonia in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

World Health Organization. Coronavirus disease (COVID-19) pandemic

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients

Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): a pooled analysis of published literature

COVID-19 in Italy: ageism and decision making in a pandemic

Early-onset dementias: diagnostic and etiological considerations

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Classification of primary progressive aphasia and its variants

The non-fluent/agrammatic variant of primary progressive aphasia

The new classification of primary progressive aphasia into semantic, logopenic, or nonfluent/agrammatic variants

The stereotypy rating inventory for frontotemporal lobar degeneration

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations

Diagnosis and management of behavioral variant frontotemporal dementia

Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia

Prefrontal cortex and the maturation of executive functions, cognitive expertise, and social adaptation. Exec Funct Front Lobes A Lifesp Perspect

Criminal behavior in frontotemporal dementia and Alzheimer disease

Violation of laws in frontotemporal dementia: a multicenter study in Japan

Caregiver burden, sleep quality, depression, and anxiety in dementia caregivers: a comparison of frontotemporal lobar degeneration, dementia with Lewy bodies, and Alzheimer's disease

Neuropsychiatric symptoms, caregiver burden and distress in behavioral-variant frontotemporal dementia and Alzheimer's disease

High caregiver burden in young onset dementia: what factors need attention? J Alzheimer's Dis

Cost related to dementia in the young and the impact of etiological subtype on cost

The social and economic burden of frontotemporal degeneration

Caregiver burden in semantic dementia with right-and left-sided predominant cerebral atrophy and in behavioral-variant frontotemporal dementia

Behavioral-variant frontotemporal dementia: distinct phenotypes with unique functional profiles

Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria

Self-consciousness in patients with behavioral variant frontotemporal dementia

Brain structural correlates of executive and social cognition profiles in behavioral variant frontotemporal dementia and elderly bipolar disorder

The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia

Functional network connectivity in the behavioral variant of frontotemporal dementia

Brain network connectivity assessed using graph theory in frontotemporal dementia

Early evidence of pronounced brain involvement in fatal COVID-19 outcomes

Emerging roles for telemedicine and smart technologies in dementia care

Diagnostic and Statistical Manual of Mental Disorders: DSM-5

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement

The PHQ-9: validity of a brief depression severity measure

A brief measure for assessing generalized anxiety disorder: the GAD-7

Quality of life enjoyment and satisfaction questionnaire -short form for quality of life assessments in clinical practice: a psychometric study

The Zarit Burden Interview: a new short version and screening version

How to cite this article

Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research